Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2' Deoxy 2',2' difluorouridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1526711A details a scalable Reformatsky process for Gemcitabine intermediates, offering high stereoselectivity and cost reduction in pharmaceutical manufacturing.